Published Online:6 Dec 2010https://doi.org/10.2217/bmm.10.100
Abstract
Male factors account for 40% of infertility cases and most are caused by low sperm count, poor sperm quality or both. Defects in sperm are directly linked to reproductive malfunctions, and these defects may be caused by genetic mutations, environmental factors and exposure to free radicals, for example. Almost half of the male infertility cases have no known cause, indicating the lack of sensitive tests for the diagnosis of infertility. Proteomics has evolved as a major research field in biology and medicine, to identify and validate potent targets, at the molecular level, for development of more sensitive diagnostic tools. The recent advances in this field focus on the identification of differentially expressed proteins and analyzing their functional aspects for better understanding of the biological pathways. It not only provides a platform to discover biomarkers of infertility, but may also help in the design of effective male contraceptives. This article discusses various insights of proteomics for exploring biomarkers of male infertility in sperm. It also discusses the enhanced understanding of reproductive physiology offered by data produced by proteomic studies of spermatozoa.
Papers of special note have been highlighted as: ▪ of interest
Bibliography
- 1 Liu DY, Clarke GN, Martic M, Garrett C, Baker HW: Frequency of disordered zona pellucida (ZP)-induced acrosome reaction in infertile men with normal semen analysis and normal semen analysis and normal spermatozoa–ZP binding. Hum. Reprod.16,1185–1190 (2001).
- 2 Bastiaan HS, Windt ML, Menkveld R, Kruger TF, Oehninger S, Franken DR: Relationship between zona pellucida-induced acrosome reaction, sperm morphology, sperm–zona pellucida binding, and in vitro fertilization. Fertil. Steril.79(1),49–55 (2003).
- 3 Turek PJ: Practical approaches to the diagnosis and management of male infertility. Nat. Clin. Pract. Urol.2,226–238 (2005).
- 4 Sipilä P, Jalkanen J, Huhtaniemi IT, Poutanen M: Novel epididymal proteins as targets for the development of post-testicular male contraception. Reproduction137(3),379–389 (2009).
- 5 Aitken RJ, Nixon B, Lin M, Koppers AJ, Lee YH, Baker MA: Proteomic changes in mammalian spermatozoa during epididymal maturation. Asian J. Androl.9,554–564 (2007).
- 6 Boerke A, Dieleman SJ, Gadella BM: A possible role for sperm RNA in early embryo development. Theriogenology68(Suppl. 1),S147–S155 (2007).
- 7 Khan SA, Suryawanshi AR, Ranpura SA, Jadhav SV, Khole VV: Identification of novel immunodominant epididymal sperm proteins using combinatorial approach. Reproduction138(1),81–93 (2009).
- 8 Canas B, Lopez-Ferrer D, Ramos-Fernandez A, Camafeita E, Calvo E: Mass spectrometry technologies for proteomics. Brief. Funct. Genomic. Proteomic.4(4),295–320 (2006).
- 9 Mann M, Kelleher NL: Precision proteomics: The case for high resolution and high mass accuracy. Proc. Natl. Acad. Sci. USA105(47),18132–18138 (2008).
- 10 Matt P, Fu Z, Fu Q, Van Eyk JE: Biomarker discovery: proteome fractionation and separation in biological samples. Physiol. Genomics33,12–17 (2008).
- 11 Pixton KL, Deeks ED, Flesch FM et al.: Sperm proteome mapping of a patient who experienced failed fertilization at IVF reveals altered expression of at least 20 proteins compared with fertile donors: case report. Hum. Reprod.19,1438–1447 (2004).
- 12 Johnston DS, Wooters J, Kopf GS, Qiu Y, Roberts KP: Analysis of the human sperm proteome. Ann. NY Acad. Sci.1061,190–202 (2005).
- 13 Martinez-Heredia J, Estanyol JM, Ballesca JL, Oliva R: Proteomic identification of human sperm proteins. Proteomics6,4356–4369 (2006).
- 14 Baker MA, Reeves G, Hetherington L, Muller J, Baur I, Aitken RJ: Identification of gene products present in Triton X-100 soluble and insoluble fractions of human spermatozoa lysates using LC-MS/MS analysis. Proteomics Clin. Appl.1,524–532 (2007).
- 15 Secciani F, Bianchi L, Ermini L et al.: Protein profile of capacitated versus ejaculated human sperm. J. Proteome Res.8(7),3377–3389 (2009).
- 16 Li LW, Fan LQ, Zhu WB et al.: Establishment of a high-resolution 2-D reference map of human spermatozoal proteins from 12 fertile sperm-bank donors. Asian J. Androl.9,321– 329 (2007).▪ Analyzed the human sperm proteome and reported visualization of 3872 distinct protein spots using narrow-range isoelectric focusing strips and multiple 2D gels.
- 17 Zhao C, Huo R, Wang FQ, Lin M, Zhou ZM, Sha JH: Identification of several proteins involved in regulation of sperm motility by proteomic analysis. Fertil. Steril.87,436–438 (2007).
- 18 Martinez-Heredia J, de Mateo S, Vidal-Taboada JM, Ballescà JL, Oliva R: Identification of proteomic differences in asthenozoospermic sperm samples. Hum. Reprod.23,783–791 (2008).▪ Reports the identification of 17 differentially expressed proteins in asthenozoospermic patients.
- 19 Siva AB, Kameshwari DB, Singh V et al.: Proteomics-based study on asthenozoospermia: differential expression of proteasome-α complex. Mol. Hum. Reprod.16(7),452–462 (2010).
- 20 Liao TT, Xiang Z, Zhu WB, Fan LQ: Proteome analysis of round-headed and normal spermatozoa by 2-D fluorescence difference gel electrophoresis and mass spectrometry. Asian J. Androl.11(6),683–693 (2009).▪ Reports the differences in protein expression between human round-headed and normal spermatozoa. Among identified proteins, nine were upregulated and 26 downregulated in round-headed spermatozoa compared with normal spermatozoa.
- 21 Baker MA, Reeves G, Hetherington L, Aitken RJ: Analysis of proteomic changes associated with sperm capacitation through the combined use of IPG-strip pre-fractionation followed by RP chromatography LC-MS/MS analysis. Proteomics10(3),482–495 (2010).▪ Analysis of the proteomic changes associated with sperm capacitation, reporting 210 significant peptide changes. A total of 52 proteins that are altered during capacitation were also identified.
- 22 Platt MD, Salicioni AM, Hunt DF, Visconti PE: Use of differential isotopic labeling and mass spectrometry to analyze capacitation-associated changes in the phosphorylation status of mouse sperm proteins. J. Proteome Res.8,1431–1440 (2009).
- 23 Ficarro S, Chertihin O, Westbrook VA et al.: Phosphoproteome analysis of capacitated human sperm. J. Biol. Chem.278(13),11579–11589 (2003).
- 24 Aitken RJ, Baker MA: The role of proteomics in understanding sperm cell biology. Int. J. Androl.31,295–302 (2008).
- 25 Wu TF, Chu DS: Sperm chromatin: fertile grounds for proteomic discovery of clinical tools. Mol. Cell. Proteomics7(10),1876–1886 (2008).
- 26 Aitken RJ, Nixon B: Proteomics of human sperm. In: Immune Infertility. Krause WK, Naz RK (Eds). Springer Verlag, Berlin, Germany, 3–12 (2009).
- 27 Gadella BM: Sperm surface proteomics. In: Immune Infertility. Krause WK, Naz RK (Eds). Springer Verlag, Berlin, Germany, 33–48 (2009).
- 28 Oliva R, de Mateo S, Estanyol JM: Sperm cell proteomics. Proteomics9,1004–1017 (2009).
- 29 Brewis IA, Gadella BM: Sperm surface proteomics: from protein lists to biological function. Mol. Hum. Reprod.16(2),68–79 (2010).▪ Highlights the importance of sperm surface proteomics for better understanding of reproductive physiology. The authors have also listed the proteomic challenges as well as strategies to improve the identification of sperm proteins.
